Skip to content

Clinical trials

Ureteral Neoplasms trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Ureteral Neoplasms Clear all

79 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20032
20041
20051
20061
20071
20082
20093
20103
20115
20121
20133
20142
20155
20164
20179
20186
20192
20202
20216
20225
20233
20245
20255
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed33
Recruiting15
Active, not recruiting14
Terminated7
Unknown status6
Withdrawn2
Suspended1
Not yet recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
National Cancer Institute (NCI)12
Eli Lilly and Company5
M.D. Anderson Cancer Center5
Mayo Clinic4
Asan Medical Center3
Changhai Hospital3
Astellas Pharma Global Development, Inc.2
Dr Anders Ullén2
Emory University2
Fox Chase Cancer Center2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Ureteral Neoplasms79
Urinary Bladder Neoplasms61
Urethral Neoplasms41
Carcinoma, Transitional Cell32
Carcinoma, Renal Cell10
Prostatic Neoplasms9
Carcinoma, Non-Small-Cell Lung7
Kidney Neoplasms7
Pancreatic Neoplasms6
Urologic Neoplasms6

Trials

Showing 76 to 79 of 79. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.